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Optimal Application of Fractional Flow Reserve to Assess Serial
Coronary Artery Disease: A 3D-Printed Experimental Study With
Clinical Validation
Bhavik N. Modi, MA, MRCP; Matthew Ryan, BSc, MRCP; Anjalee Chattersingh, MSc; Kseniia Eruslanova, MSc; Howard Ellis, BSc;
Nicholas Gaddum, BEng, PhD; Jack Lee, BEng, PhD; Brian Clapp, MA, PhD, FRCP; Phil Chowienczyk, PhD, FRCP; Divaka Perera, MA, MD, FRCP
Background-—Assessing the physiological signiﬁcance of stenoses with coexistent serial disease is prone to error. We aimed to
use 3-dimensional-printing to characterize serial stenosis interplay and to derive and validate a mathematical solution to predict
true stenosis signiﬁcance in serial disease.
Methods and Results-—Fifty-two 3-dimensional-printed serial disease phantoms were physiologically assessed by pressure-wire
pullback (DFFRapp) and compared with phantoms with the stenosis in isolation (DFFRtrue). Mathematical models to minimize error
in predicting FFRtrue, the FFR in the vessel where the stenosis is present in isolation, were subsequently developed using 32
phantoms and validated in another 20 and also a clinical cohort of 30 patients with serial disease. DFFRapp underestimated
DFFRtrue in 88% of phantoms, with underestimation proportional to total FFR. Discrepancy as a proportion of DFFRtrue was 17.1%
(absolute difference 0.0360.048), which improved to 2.9% (0.0060.023) using our model. In the clinical cohort, discrepancy
was 38.5% (0.050.04) with 13.3% of stenoses misclassiﬁed (using FFR <0.8 threshold). Using mathematical correction, this
improved to 15.4% (0.020.03), with the proportion of misclassiﬁed stenoses falling to 6.7%.
Conclusions-—Individual stenoses are considerably underestimated in serial disease, proportional to total FFR. We have shown
within in vitro and clinical cohorts that this error is signiﬁcantly improved using a mathematical correction model, incorporating
routinely available pressure-wire pullback data. ( J Am Heart Assoc. 2018;7:e010279. DOI: 10.1161/JAHA.118.010279.)
Key Words: coronary artery disease • fractional ﬂow reserve • percutaneous coronary intervention
G rowing evidence supports ischemia-guided revascular-ization for coronary artery disease (CAD).1 Ischemia
assessment has now evolved to be able to assess physiolog-
ically signiﬁcant disease in speciﬁc vessels, at the time of
diagnostic angiography. This involves calculating the ratio of
distal coronary pressure to aortic pressure at maximal
hyperemia (fractional ﬂow reserve, FFR),2 at rest during the
entire cardiac cycle (Pd/Pa)
3 or at rest during a deﬁned-phase
of diastole (instantaneous wave-free ratio, iFR).4 Physiology-
guided revascularization appears to confer signiﬁcant clinical
and prognostic beneﬁt over management based on angio-
graphic appearance alone.5–7
While these pressure-derived indices are well established
and validated for vessels with single lesions, given the
systemic nature of atherosclerosis, coronary stenoses are
often found in tandem with other focal or diffusely diseased
segments within the same vessel. In such instances, the
decision to revascularize and the mode of revascularization
chosen rely on identifying the true individual contribution of
lesions and not just the cumulative impact of disease in the
entire vessel. However, each diseased segment affects the
ﬂuid dynamics of the other, which makes it difﬁcult to
apply conventional physiological techniques to identify the
true signiﬁcance of a lesion within a serially diseased
vessel.8,9 Knowing the true functional signiﬁcance of each
stenosis enables the appropriate stenosis to be targeted
and helps ensure the correct revascularization strategy is
chosen, whether this is percutaneous coronary
intervention (PCI), coronary artery bypass graft, or medical
therapy.
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Theoretical solutions have been developed that involve
complex formulae10 using measurements of intracoronary
pressure at various points in the artery and determination of
coronary wedge pressure, which in turn is acquired during
transient balloon occlusion of the vessel.8,11 The rationale for
incorporating a wedge pressure measurement was to stan-
dardize and account for variability in collateral ﬂow across a
stenosis.11 A major drawback of this technique, which has
limited the adoption of these formulae in clinical practice, is
that in order to obtain a wedge pressure measurement, it is
necessary to balloon occlude the coronary artery, which
carries a risk of dissection. This could have clinical sequelae if
angiographically undetectable at the time, or if detected, may
mandate stenting regardless of the results of physiological
assessment. Other solutions to this problem have relied on
the identiﬁcation of a large disease-free side branch12,13 to
separate the true signiﬁcance of a proximal stenosis, although
this scenario is only applicable to left main coronary artery
disease where one of the daughter vessels is free of disease.
Furthermore, the relative accuracy of hyperemic versus
resting indices, such as iFR,14 in the context of serial disease
is unknown.
The aim of this study was ﬁrst to develop an in vitro model,
based on 3-dimensional (3D)-printed conﬁgurations of tandem
disease, that is a realistic representation of pulsatile coronary
circulation in hyperemic conditions. Using these results, we
aimed to characterize the factors that inﬂuence serial stenosis
hemodynamic interplay and incorporate them in a theoretical
model to improve prediction of the true FFR of individual
stenoses, without the need for wedge pressure measure-
ments or angiographic guesses of stenosis and vessel
diameters. We then sought to test such a solution within a
clinical cohort of patents with serial CAD.
Methods
The data, analytic methods, and study materials will not be
made available to other researchers for purposes of repro-
ducing the results or replicating the procedure.
Creating a Model of Tandem Coronary Artery
Disease
To model tandem disease, phantom tubes were created by 3D
printing (Objet 500 Connex3TM; 600960091600 dpi) from
the biocompatible “TangoPlus FullCure PolyJet” photopolymer
material (Objet Ltd, Israel) that has been shown to adequately
model arterial compliance.15 The tubes created were 150 mm
long, with an internal diameter of 5 mm and wall thickness of
2 mm to simulate the dimensions and compliance of a typical
left anterior descending artery (Figure 1). A continuous ﬂow
model of coronary circulation was created to facilitate
accurate measurement of pressure changes (Figure 2). Con-
tinuous inlet pressure was created by using an electrically
driven water pump and capacitance chamber that connected
to an aorta modeled from PolyJet tubing, with aortic pressure
kept ﬁxed. PolyJet tubing, modeling the left main coronary
artery, then branched off the aorta with the 3D-printed
phantom attached, ensuring any connections themselves did
not pose additional resistance (Figure 2). A ﬁxed-length low-
compliance silicon tubing was added downstream of the
phantom tube and calibrated to create similar resistance to
the coronary microcirculation during adenosine-induced
hyperemia. Distilled water was used as the ﬂuid for all
experiments, in line with previous in vitro models of coronary
circulation16,17 that presume Newtonian conditions are main-
tained within coronary arteries under physiological
conditions.18 The use of 3D printing enabled all stenoses to
have a ﬁxed geometry to reduce variability in other factors
inﬂuencing the pressure drop across a stenosis.19
The in vitro model was validated using the following tests
(detailed in Figure S1): (1) A comparison of pressure
measurements across a range of stenoses from our contin-
uous-ﬂow model against measurements from a previously
validated pulsatile ﬂow model.20 (2) Triplicate pressure
gradient measurements for each stenosis allowing calculation
of intraclass correlation to ensure high test–retest reliability.
(3) The compliance of 3D-printed tubes was assessed by
creating pressure–volume loops in a blank tube made of the
same material, and compared with published data on coronary
artery compliance.15 (4) The effect of luminal area reduction
on the pressure drop across each stenosis was assessed and
Clinical Perspective
What Is New?
• Individual stenoses are considerably underestimated in
serial disease, proportional to total fractional ﬂow reserve.
• This study provides operators with a simple mathematical
correction model to reduce this error that can be readily
incorporated into routine daily practice.
What Are the Clinical Implications?
• Our ﬁndings should make operators wary when attempting
to identify the individual physiological signiﬁcance of
stenoses in serially diseased vessels, particularly when the
total vessel fractional ﬂow reserve is low.
• We provide operators with a mathematical correction
model, incorporating routinely available pressure-wire pull-
back data, to minimize the error of performing fractional
ﬂow reserve assessment of the physiological signiﬁcance of
individual stenosis.
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compared with previously reported coronary physiological
data of pressure drops across stenoses in hyperemic
conditions.19 (5) Volumetric ﬂow rates measured at the end
of the tandemly diseased phantom tubes were measured and
plotted against pressure-drops for each stenosis, enabling
comparison with accepted pressure–ﬂow relationships.19,21
Measurement of FFR
Using this setup, a pressure wire (Phillips VolcanoTM) was
normalized to aortic pressure and advanced distal to the serial
lesions. Total vessel FFR was calculated conventionally as the
ratio of distal coronary pressure to aortic pressure, with
conditions presumed equivalent to hyperemia given the
continuous ﬂow set-up with ﬁxed and minimal distal resis-
tance. The pressure-wire was pulled back through the lesions
at 1 mm/s using a modiﬁed pullback device (Phillips Volcano
R100) to generate FFR pullback curves with all experiments
repeated in triplicate; mean values from these are quoted
throughout (Figure 1). Each 3D-printed conﬁguration of
tandem disease (varying in length of stenoses, separation,
and severity) was then replaced with the corresponding 3D-
printed tube containing the isolated stenosis to simulate
treatment with coronary angioplasty (PCI) (Figure 1).
For a given stenosis, the apparent trans-stenotic pressure
gradient (which in turn gives rise to ΔFFRapp, assuming a ﬁxed
Pa) is the change in pressure across a given lesion when the
measurement was made in the presence of both lesions,
whereas the actual trans-stenotic pressure gradient (which
gives rise to ΔFFRtrue, again assuming a ﬁxed Pa) is when that
stenosis is present in isolation, with the accompanying
stenosis removed (Figure 1). The extent of serial stenosis
hemodynamic interplay was assessed by examining the
magnitude of difference between ΔFFRapp and ΔFFRtrue, with
various combinations of serial disease. The impact of the
following on this difference was assessed: average severity (%
diameter reduction) of both stenoses, length of stenoses
(both physical length from 3D-printed geometries and phys-
iological length from pullback traces performed at 1 mm/s),
physical separation distance between the serial stenoses, and
the position of the stenosis in question (ie, proximal or distal
to the accompanying stenosis).
Figure 1. How 3-dimensional (3D) printing was used to model pressure-wire measurements in serial
disease. Top: Photographs of a 3D-printed tube modeling tandem lesions with a pressure-wire pullback
demonstrating distal coronary pressure (Pd), pressure between lesions (Pm), and aortic pressure (Pa).
ΔFFRapp represents the apparent pressure gradient across a stenosis when in the presence of another. Also
demonstrated is the phenomenon of pressure recovery after a tight stenosis, showing further evidence of
our model replicating in vivo physiology. Bottom: 3D-printed tube with the corresponding single stenosis in
isolation. ΔFFRtrue represents the true pressure gradient across a stenosis.
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Generation of Equations to Predict FFRtrue and
Validation in a Clinical Cohort
Mathematical solutions to predict FFRtrue, the FFR in the
vessel if the stenosis was present in isolation, were derived
from the results within a derivation cohort of the in vitro study
(see details in the Results section) and then tested within a
small validation cohort of phantoms.
To demonstrate the clinical applicability of such a solution
within real-world cases of serial CAD, this solution was
subsequently also tested in a clinical cohort of 30 patients
with stable angina and coronary angiography that demon-
strates serial disease within a main epicardial coronary artery
(≥2 stenoses of >30% diameter reduction, at least 10 mm
apart, with a plan to treat 1 lesion by PCI). All patients within
the catheter laboratory cohort were loaded with 300 mg
aspirin and 600 mg clopidogrel before being catheterized via
the right radial artery using a standard 6F sheath with
sedation, intra-arterial nitrates, and weight-adjusted heparin
(70 l/kg) given as standard. Following diagnostic angiogra-
phy, an intracoronary pressure wire was inserted, calibrated,
and manipulated to the distal vessel. A pullback of the
pressure wire was subsequently performed during IV
adenosine infusion (at a dose of 140 lg/kg per minute via
an antecubital vein) before intervention, using the same
1 mm/s mechanical pullback method described for the
in vitro study, with measurements made of the pressure
gradient across each lesion in the presence of another
(ΔFFRapp).
In the clinical setting, FFRtrue was assessed following PCI of
1 of the 2 stenoses, with the treated lesion chosen by the
operator using their standard clinical techniques. PCI was
performed with 2nd/3rd-generation drug-eluting stents with
optimization using intravascular imaging where appropriate.
The UK National Research Ethics Service approved the
protocol in January 2016 (London Bridge Research Ethics
Committee reference 15/LO/2011). All patients provided
written informed consent before being enrolled in the
study.
Statistical Analysis
Data were analyzed using SPSS Statistics version 22 (released
2013; Armonk, NY: IBM Corp) and Graph Pad Prism Version
7.0a for Mac OS X. Data are expressed as meanSD unless
stated otherwise. Paired t tests were used to compare
continuous variables after normality of data was visually
assessed using histograms and Q-Q plots. For all statistical
analysis, P<0.05 is considered statistically signiﬁcant. An
Figure 2. Diagrammatic representation of in vitro model of coronary circulation. Diagrammatic
Representation of Continuous Flow Phantom model used to model serial stenosis hemodynamic interplay.
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empirical correction equation was developed using stepwise
simple linear regression modeling. Details of the theoretical
correction equation are stated in Figure S2. The incremental
value of the correction equation compared with FFRapp from a
conventional pressure-wire pullback was determined by the
proportion of cases where an incorrectly classiﬁed lesion
(according to FFR threshold of 0.8) was correctly reclassiﬁed.
Results
In Vitro Model
Measurements of translesional pressure drop in the contin-
uous-ﬂow model showed high test–retest reliability (intraclass
correlation of 3 measurements for each lesion 0.97, P<0.05).
The model demonstrated a nonlinear relationship between
stenosis severity (quantiﬁed by diameter stenosis) and
pressure gradient. In addition, the compliance and hysteresis
loops generated by varying pressure and ﬂow were similar to
those reported in vivo.22 The model also showed strong
statistical agreement (r=0.94, P<0.05) with measurements
made in the previously validated pulsatile model.20 Further-
more, using volumetric ﬂow-rate measurements distal to the
3D-printed phantoms, we were able to replicate accepted
pressure drop versus ﬂow velocity relationships.19 Validation
data are summarized in Figure S1. In addition, as described in
Figure 1, the concentric stenosis geometry meant that for
severe lesions the phenomenon of “pressure recovery” was
often observed because of the Bernoulli effect. Where any
pressure recovery was observed (Figure 1), the pressure
immediately proximal to the distal lesion, before pressure
recovery phase, was taken as the interstenotic pressure to
calculate ΔFFRapp and ΔFFRtrue.
In total, 52 combinations of tandem lesions were analyzed
in vitro with average stenosis diameter stenosis of 55% and
overall vessel FFR of 0.660.23. There was a signiﬁcant
difference between FFRapp and FFRtrue, with the true contri-
bution of a given lesion being underestimated in the presence
of an additional lesion in 85% of cases. The overall difference
between the FFRapp and FFRtrue was 17.1%, as a proportion of
ΔFFRtrue (absolute difference 0.0360.048) with increasing
lesion underestimation and variance between FFRapp and
FFRtrue with increasing cumulative burden of disease (repre-
sented by total FFR) (Figure 3). The degree of this underes-
timation was similar (P>0.05), regardless of whether the distal
stenosis or proximal stenosis was removed.
The 3D-printed model also enabled assessment of other
factors on the extent of serial stenosis interplay including
lesion length, distance between lesions, and physiological
length. Results showed that none of these other factors
correlated signiﬁcantly with the extent of serial stenosis
underestimation (P>0.05). Furthermore, we found no rela-
tionship between the ﬁnding of pressure-recovery and the
extent of serial stenosis interplay.
Figure 3. Results demonstrating the error in assessing pressure gradients in serial disease and how this
can be corrected by applying correction equations generated from in vitro study. Left: In the full cohort of
52 tandemly diseased phantoms (with corresponding tube of stenoses in isolation), results demonstrated a
signiﬁcant (P<0.001) overestimation of FFRtrue (and therefore an underestimation of stenosis signiﬁcance):
The more the data-point is above the x-axis, the greater the underestimation of a stenosis. The difference
between FFRapp and FFRtrue and the variance of this difference was greater with increasing burden of total
disease in the vessel (lower total FFR). Right: In a randomly selected validation cohort of 20 phantoms, the
error in estimating FFRtrue was signiﬁcantly reduced with the statistical regression equation (Eqn 1) with the
variance and difference even further reduced using the theoretical correction equation (Eqn 2), based on
knowledge of Pd and ΔP across the stenosis. FFRapp indicates apparent pressure gradient across a stenosis;
FFRpred, predicted pressure gradient across a stenosis; FFRtrue, true pressure gradient across a stenosis;
Pd, distal coronary pressure.
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Developing Algorithms to Predict FFRtrue
Our study showed total FFR and the magnitude of the
pressure drop to be the strongest determinants of error in
determining the physiological signiﬁcance of each lesion.
Based on these ﬁndings, 2 solutions were created to predict
the true FFR of each stenosis: one empirically derived from
regression modeling of the results from this study and the
second from mathematical modeling of pressure drop and Pd
from theoretical principles.
Empirical regression model
Based on the correlations observed in our study, multiple
linear regression was performed to predict FFRtrue (ie, residual
FFR if the stenosis in question was present in isolation) from
ΔFFRapp following a ﬁxed-rate pullback maneuver, using total
vessel FFR as an input. This equation was created in a
randomly selected derivation cohort of 32 and is summarized
as follows:
FFRpredicted ¼ 0:9 ðDFFRapp  Total FFR 0:11Þ
FFRpredicted ¼ 1 DPPd þ DP
Although such a regression model is constrained by the
parameters used in this experiment, we were able to perform
proof-of-concept validation in the remaining 20 tandemly
diseased tubes. We found the initial discrepancy versus
ΔFFRtrue was 17.1% (0.0360.048) and improved signiﬁcantly
to 2.1% (0.0050.04) with this equation, albeit still with a
large degree of variance (Figure 3).
Theoretical model
The relationship between pressure and ﬂow is curvilinear, but
it has been established that most physiological measure-
ments during hyperemia will fall within a relatively linear part
of the curve. Our theoretical model of FFR estimation was
therefore based on the assumptions of a linear pressure-ﬂow
relationship. In this condition, the hemodynamic equivalent of
Ohm’s law is applicable, whereby the individual resistances of
stenoses and the distal circulation stay ﬁxed regardless of
other stenoses being removed. Under these conditions, the
theoretical FFR can be derived, without the need for a wedge
pressure if we assume the variability of collateral ﬂow across
intermediate stenoses is minimal (see Figure S2 for full
details):
In this equation, DP refers to the pressure drop across a
lesion in the presence of serial disease and Pd refers to distal
pressure. This relationship applies for both proximal and distal
lesions and depends neither on the perfusion pressure (Pa),
nor the distal resistance R, and is solely a function of the
measured pressure values. Using this equation, evaluation
against the n=20 in vitro validation cohort yielded a markedly
improved discrepancy of only 0.6% (0.0060.02) against
ΔFFRtrue measurements (Figure 3). Given the more favorable
results of this solution and the fact it was derived using ﬁrst
principles, not constrained by the model conditions from
which it was derived, we then proceeded to test its
performance in a clinical cohort of serial CAD.
Testing Algorithms to Predict FFRtrue in Clinical
Cohort
In the clinical cohort, mean total vessel FFR was 0.700.11
(see Table for further details of the vessels studied). These
vessels contained tandem stenoses with mean diameter
stenosis (by Quantitative Coronary Analysis) of 57.76.1%.
Within this clinical cohort, the relative discrepancy of FFRapp
and FFRtrue was 38.5% (absolute difference 0.050.04), with
no signiﬁcant difference seen regardless of whether the
proximal or distal lesion was being assessed. This improved
signiﬁcantly (P<0.001 by paired analysis) to 15.4% (absolute
difference 0.020.03) with the theoretical correction equa-
tion (Figure 4). Importantly, in 4 out of 30 cases (13.3%),
signiﬁcant lesions were misclassiﬁed as nonsigniﬁcant using
uncorrected FFR pullback alone (wrongly estimating that the
residual FFR would have been ≥0.8 if the lesion was present in
isolation). By applying the correction equation, lesions were
misclassiﬁed in only 2 out of 30 cases (6.7%).
Table. Patient Demographic Data for Clinical Validation
Cohort
Age, y 6212
Male 27 (90)
Hypertension 18 (60)
Diabetes mellitus 10 (33)
Smoker 5 (17)
Hyperlipidemia 24 (80)
Tandemly diseased vessel
LM—LAD 5 (17)
LAD 17 (57)
LCx 2 (7)
RCA 6 (20)
Lesion severity, QCA, % 57.76.1
Lesion length, QCA, mm 9.65.2
Distance between stenoses, mm 17.37.8
Values are n, n (%), or meanSD. LAD indicates left anterior descending artery; LCx, left
circumﬂex artery; LM, left main coronary artery; QCA, quantitative coronary angiography;
RCA, right coronary artery.
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Both within the in vitro and clinical validation cohorts,
factors such as lesion length, lesion separation, and location
of lesions did not signiﬁcantly inﬂuence the performance of
the equations in predicting FFRtrue. Unlike the in vitro
cohort, we found that within the clinical validation cohort,
signiﬁcant pressure recovery was rarely found: a likely
reﬂection of the fact that stenosis geometry is complex and
nonconcentric. Where it was observed, as in the in vitro
study, the straight line of pressure between lesions, before
pressure recovery phase, was used to calculate FFRapp and
FFRtrue.
Discussion
The main ﬁndings of this study are as follows:
1. A physiologically representative model of serial CAD can
be created in vitro using a continuous-ﬂow model based on
3D printing.
2. Within our model, we have demonstrated that stenosis
underestimation commonly occurs when physiologically
assessing serial CAD, regardless of whether a proximal
stenosis is present alongside a more distal stenosis or vice
versa. This underestimation is proportional to cumulative
disease burden (the lower the total vessel FFR, the greater
the likelihood of stenosis underestimation).
3. Using a theoretical solution derived from our in vitro
experiments, we have created and validated an equation,
derived from ﬁrst principles, to predict to true functional
signiﬁcance of stenoses, using readily available data from
routine pressure-wire pullback measurements.
4. Within a clinical cohort, we have again shown signiﬁcant
underestimation of stenosis signiﬁcance in serial CAD,
with mean proportional error of 38.5% (0.050.04), which
improved to 15.4% (0.020.03) using the prediction
equation. Importantly, within this clinical cohort, 13.3%
of all lesions studied were originally misclassiﬁed in the
presence of serial disease, but with our mathematical
solution, the misclassiﬁcation rate more than halved, with
only 6.7% of lesions misclassiﬁed.
The unique beneﬁts of precisely controlling lesion geom-
etry with 3D printing have enabled us to overcome many
limitations of previous work in the ﬁeld, where stenoses were
created with external ties and clamps.8,17 This has enabled us
to show that the factors that most inﬂuence the error when
predicting individual lesion signiﬁcance in serial disease are
total vessel FFR, average % diameter stenosis of the tandem
stenoses, and pressure drop across the lesion in question.
Other factors such as lesion separation and lesion length
appear less important, with a statistically nonsigniﬁcant
relationship with lesion underestimation. These ﬁndings are
unsurprising because the % luminal narrowing caused by a
stenosis contributes to both the linear and square coefﬁcients
within the equation that relates stenosis geometry to the
pressure drop across it and as stated by Poiseuille’s law, the
resistance to ﬂow is related to the 4th power of radius of the
vessel.23
Compared with the in vitro cohort, in the clinical cohort we
found greater residual error in estimating true physiological
signiﬁcance of a stenosis, despite the correction equa-
tion (15.4%). This is likely to reﬂect stenosis geometry
variation that may alter the separation coefﬁcient and
turbulent conditions within a vessel. Furthermore, the lesions
studied clinically showed greater variability in lesion length
(Table), and although we have found this factor to not be as
important in inﬂuencing serial stenosis underestimation, it is
still likely to play a role, because it is an important contributor
to both the frictional and separation coefﬁcient of a stenosis.
In addition, in the 3D-printed in vitro setting, where we can
replace a tandemly diseased phantom with the relevant
isolated stenosis phantom, we get “perfect” revascularization
with very little diffuse disease in the rest of the vessel. In the
clinical setting, we know that this is more difﬁcult to achieve
with some degree of residual pressure gradient being
common.24
Within the clinical cohort, the error because of serial
stenoses of 0.050.04 may not initially seem signiﬁcant at
Figure 4. Predicting FFRtrue: clinical validation of correction
equation. Left: Column scatterplot demonstrating the error in
assessing FFRtrue in the presence of accompanying disease (error
0.050.04; 38.5% as a proportion of true pressure gradient).
Right: Column scatterplot demonstrating signiﬁcant reduction in
error in assessing FFRtrue using our theoretically modeled
correction equation (0.020.03, 15.4% as a proportion of true
pressure gradient). FFRapp indicates apparent pressure gradient
across a stenosis; FFRpred, predicted pressure gradient across a
stenosis; FFRtrue, true pressure gradient across a stenosis.
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ﬁrst glance but when compared with the mean change in FFR
across the stenoses in question, we have shown it amounts to
an error of >30%. Perhaps more signiﬁcantly, current clinical
guidelines recommend we use a single threshold to indicate
whether we perform or defer revascularization (for FFR the
contemporary threshold now stands at 0.8).6 When applying
these rigid thresholds to the individual lesions without our
clinical data set, we found 13.3% of lesions were misclassiﬁed
(using an FFR threshold of signiﬁcance as <0.8). With the use
of our equation, this rate of misclassiﬁcation halved to 6.7%. If
these were cases of serial stenoses involving the left main
coronary artery, this could potentially mean we can more than
halve the rate of inappropriate revascularization strategies
being chosen on the basis of physiology.
Our study represents a signiﬁcant advance in evaluating
tandem stenoses. For the ﬁrst time we have been able to
objectively evaluate the nature of serial stenosis interplay
using novel 3D printing of CAD. We have subsequently
generated a correction equation, not requiring the measure-
ment of wedge pressure between lesions, that is solely based
on routine pressure-wire pullback measurements and shown a
signiﬁcant improvement in the prediction of the true physi-
ological signiﬁcance of lesions within a clinical cohort of 53
patients. The only previous study with clinical validation of an
in vitro solution to use with FFR was in a smaller cohort of
32 patients with results similar to our own but with
the requirement of measuring wedge pressure between
stenoses.8,11 Importantly, our solution does not need wedge
pressure measurements and so requires no ballooning or the
need to mandate starting PCI before the optimum revascu-
larization strategy is chosen. In Figure S3, we describe an
example clinical case of serial CAD that demonstrates the
utility of the mathematical correction model we have
described.
In this study, our goal was to derive a simple (even if
imperfect) solution based on information that is readily and
routinely available in the catheter laboratory. Extracting
accurate geometric information from a standard coronary
angiogram is difﬁcult, with quantitative coronary analysis
seeming both retrograde and inadequate. However, when
lesion characteristics (which can be accurately obtained in the
3D-printed phantom) were incorporated, the predictive accu-
racy of the mathematical solution was even better than with
intracoronary pressure–based inputs alone, suggesting even
more improvement is possible if in vivo 3D stenosis geometry
were to be characterized better. Future directions will involve
applying some of the ﬁndings of our work to computed
tomography and FFRCT outputs in patients who have had prior
computed tomography imaging, because the latter lends itself
to improved geometric characterization.
In summary, this study has developed a mathematical
correction model that signiﬁcantly improves the prediction of
true stenosis signiﬁcance in serial CAD. The next steps will be
to carry out a multicenter clinical study to test the clinical
utility of our corrected FFR pullback solution and also to
compare it with other conventional techniques, including
resting indices such as iFR pullback.14
Limitations
Tandem stenoses within humans are rarely found in other-
wise smooth vessels, as has been modeled within our 3D-
printed phantoms. The reality is that between stenoses,
diffuse atheroma acts as a continuous mild stenosis and this
is likely to represent one of the reasons why the equa-
tion was shown to perform less well in the clinical cohort,
albeit still resulting in a signiﬁcant improvement to current
methods.
An ideal model for predicting FFRtrue would be based on
the varying curvilinear relationships between pressure and
ﬂow but this would not be possible from pressure measure-
ments alone. We acknowledge this may be one of the reasons
there is still some residual error when using a correction
equation that is based on a linear pressure-ﬂow relationship in
physiological conditions. By doing so, however, we have been
able to establish a simple model utilizing pressure-wire data,
without the need for simultaneous ﬂow or wedge pressure
measurement, which represents a signiﬁcant improvement to
current methods as evident in the clinical and phantom
validation cohorts.
The use of resting physiological indices, particular iFR, has
been growing for the assessment of serial disease, with
proponents suggesting that without hyperemia, there is less
serial stenosis hemodynamic interplay. Before universal
adoption, the FFR correction model would require an assess-
ment of its performance against other physiological indices
commonly used in serial disease, such as iFR.
Conclusions
This study demonstrates that estimation of the true stenosis
signiﬁcance in serial disease is prone to signiﬁcant underes-
timation using FFR, regardless of whether is there is
accompanying distal or proximal disease. 3D-printed modeling
of tandem disease has enabled us to generate and test a
mathematical equation to improve estimation of the true
physiological impact of each stenosis, using readily available
measurements from a routine pressure-wire study. Within a
clinical validation cohort, using measurements after isolation
of the stenosis following PCI, we have shown that incorpo-
rating this equation into conventional FFR assessments can
signiﬁcantly improve the prediction of the true lesion signif-
icance, with a large reduction in stenosis misclassiﬁcation.
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Figure S1. Validation of in vitro Model of Coronary Circulation. 
 
 
 
Summary of Results from Model Validation Experiments. A: Intra-class Correlation Table for both 
individual and mean measurements of Delta FFR. B: Scatterplot showing the effect of lesion severity 
(% diameter reduction) on delta FFR. C: Pressure-volume loop acquired in the compliance testing. 
Data represent mean ± standard deviation. D: Continuous vs. Pulsatile flow system Spearman 
correlation analysis test. E: Scatterplot demonstrating the quadratic relationship between volumetric 
flow velocity impairment (versus blank tube with no stenoses) and the pressure drop within the 
tandemly diseased tubes 
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Figure S2. Theoretical Model Derivation. 
 
 
Consider the pressure and resistance distribution in a vessel with tandem lesions pre and post-PCI 
(Figure below). For illustration it is assumed that the distal lesion (R2) is treated in this derivation, 
however, the outcome is identical if the proximal lesion is removed instead. 
 
Since it is assumed that the resistance of the untreated lesion remains unchanged (i.e. R1 and R2 are 
independent) and flow remains constant throughout the vessel (i.e. no side-braches between the 
lesions), Ohm’s law applied to pre- and post-PCI setting leads to:         
𝑄𝑝𝑟𝑒 =
∆𝑃𝑝𝑟𝑒
𝑅1
      and   𝑄𝑝𝑜𝑠𝑡 =
∆𝑃𝑝𝑜𝑠𝑡
𝑅1
 
which can be combined to give                  
𝑄𝑝𝑜𝑠𝑡
𝑄𝑝𝑟𝑒
=
∆𝑃𝑝𝑜𝑠𝑡
∆𝑃𝑝𝑟𝑒
      (1) 
In addition, similar expressions can be written for the distal resistance Rd (which is assumed to be 
fixed): 
𝑄𝑝𝑟𝑒 =
𝑃𝑑
𝑅𝑑
 
𝑄𝑝𝑜𝑠𝑡 =
𝑃𝑎 − ∆𝑃𝑝𝑜𝑠𝑡
𝑅𝑑
 
which combine to give 
 
𝑄𝑝𝑜𝑠𝑡
𝑄𝑝𝑟𝑒
=
𝑃𝑎−∆𝑃𝑝𝑜𝑠𝑡
𝑃𝑑
 (2) 
Equations (1) and (2) can be used together to eliminate flows 
∆𝑃𝑝𝑜𝑠𝑡
∆𝑃𝑝𝑟𝑒
=
𝑃𝑎 − ∆𝑃𝑝𝑜𝑠𝑡
𝑃𝑑
 
Distal Stenosis Proximal	Stenosis
Pm
Pd
Pd
Pa
Pa
Ppre
Ppost
Rd R1Qpre
Qpost R1
R2
Rd
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Rearranging for ∆𝑃𝑝𝑜𝑠𝑡 yields the following expression 
 ∆𝑃𝑝𝑜𝑠𝑡 =
∆𝑃𝑝𝑟𝑒𝑃𝑎
𝑃𝑑+∆𝑃𝑝𝑟𝑒
 (3) 
Now, using the definition of post-PCI FFR 
𝐹𝐹𝑅𝑚𝑜𝑑𝑒𝑙 =
𝑃𝑎 − ∆𝑃𝑝𝑜𝑠𝑡
𝑃𝑎
= 1 −
∆𝑃𝑝𝑜𝑠𝑡
𝑃𝑎
= 1 −
∆𝑃𝑝𝑟𝑒
𝑃𝑑 + ∆𝑃𝑝𝑟𝑒
 
where equation (3) has been used in the last step.  
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Figure S3. Example Clinical Case Demonstrating Utility of Mathematical Correction 
Model. 
 
 
LAD demonstrating serial lesions. 
 Question about what the residual FFR would 
be due to distal lesion once proximal LAD 
lesion treated 
 
 
distal FFR of 0.75 
(distal Pd of 86.4mmHg) 
hyperemic pressure-wire 
pullback demonstrating 
apparent P and apparent 
FFR 
without model, it would be 
estimated that residual FFR 
from distal stenosis only 
would be 0.90 
 
 
𝑭𝑭𝑹𝒎𝒐𝒅𝒆𝒍 = 𝟏 −
∆𝑷𝒑𝒓𝒆
𝑷𝒅 + ∆𝑷𝒑𝒓𝒆
= 𝟏 −
𝟏𝟔. 𝟖
𝟏𝟎𝟑. 𝟐
= 𝟎. 𝟖𝟒 
with equation, residual FFR following PCI of proximal lesion estimated to be 0.84 
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